Table of Contents

company-logo

Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan, which is in Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. Phathom Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Florham Park, New Jersey.

Phathom Pharmaceuticals Dividend Announcement

• Phathom Pharmaceuticals does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Phathom Pharmaceuticals dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Phathom Pharmaceuticals Dividend History

Phathom Pharmaceuticals Dividend Yield

Phathom Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Phathom Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

Phathom Pharmaceuticals Financial Ratios

P/E ratio-3.33
PEG ratio0.03
P/B ratio-4.52
ROE158.12%
Payout ratio0.00%
Current ratio5.73
Quick ratio5.68
Cash Ratio5.13

Phathom Pharmaceuticals Dividend FAQ

Does Phathom Pharmaceuticals stock pay dividends?
Phathom Pharmaceuticals does not currently pay dividends to its shareholders.
Has Phathom Pharmaceuticals ever paid a dividend?
No, Phathom Pharmaceuticals has no a history of paying dividends to its shareholders. Phathom Pharmaceuticals is not known for its dividend payments.
Why doesn't Phathom Pharmaceuticals pay dividends?
There are several potential reasons why Phathom Pharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Phathom Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Phathom Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Phathom Pharmaceuticals a dividend aristocrat?
Phathom Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Phathom Pharmaceuticals a dividend king?
Phathom Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Phathom Pharmaceuticals a dividend stock?
No, Phathom Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Phathom Pharmaceuticals stocks?
To buy Phathom Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Phathom Pharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.